Literature DB >> 12432040

Cyclin E and prognosis in patients with breast cancer.

Robert L Sutherland1, Elizabeth A Musgrove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12432040     DOI： 10.1056/NEJMNEJMp020124

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability.

Authors:  Fanny Lemée; Valérie Bergoglio; Anne Fernandez-Vidal; Alice Machado-Silva; Marie-Jeanne Pillaire; Anne Bieth; Catherine Gentil; Lee Baker; Anne-Laure Martin; Claire Leduc; Elena Lam; Eddy Magdeleine; Thomas Filleron; Naïma Oumouhou; Bernd Kaina; Mineaki Seki; Fanny Grimal; Magali Lacroix-Triki; Alastair Thompson; Henri Roché; Jean-Christophe Bourdon; Richard D Wood; Jean-Sébastien Hoffmann; Christophe Cazaux
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

Review 2.  Evolving therapies and FAK inhibitors for the treatment of cancer.

Authors:  Kelli Bullard Dunn; Melissa Heffler; Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

3.  Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer.

Authors:  Serena Bonin; Davide Brunetti; Elena Benedetti; Nader Gorji; Giorgio Stanta
Journal:  Virchows Arch       Date:  2006-01-27       Impact factor: 4.064

4.  The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing.

Authors:  Hanh H Nguyen; Ida Aronchik; Gloria A Brar; David H H Nguyen; Leonard F Bjeldanes; Gary L Firestone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

5.  Identification of prognostic biomarkers for glioblastomas using protein expression profiling.

Authors:  Yong Jung; Kyeung Min Joo; Dong Ho Seong; Yoon-La Choi; Doo-Sik Kong; Yonghyun Kim; Mi Hyun Kim; Juyoun Jin; Yeon-Lim Suh; Ho Jun Seol; Chul Soo Shin; Jung-Il Lee; Jong-Hyun Kim; Sang Yong Song; Do-Hyun Nam
Journal:  Int J Oncol       Date:  2011-12-15       Impact factor: 5.650

6.  Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A.

Authors:  Tessa J Murray; Xinhai Yang; David H Sherr
Journal:  Breast Cancer Res       Date:  2006-03-27       Impact factor: 6.466
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.